StockWatch
·
Pharmaceuticals
Quarterly Result28 May 2026, 07:06 pm

531398 Q4/FY26 Net Sales ₹21.03 Cr, Profit ₹2.01 Cr; CFO Resigns

AI Summary

Company 531398 announced its audited financial results for the quarter and year ended March 31, 2026. For Q4 FY26, Net Sales from Operations were ₹21.03 Cr and Profit from Operations was ₹2.01 Cr. For the full fiscal year 2026, Net Sales from Operations reached ₹70.38 Cr, with Profit from Operations at ₹4.92 Cr. The Board approved these results, noting an unmodified audit opinion. Additionally, the Board re-appointed M/s Ganga Prakash & Co. as Internal Auditors and M/s Chiranjeevulu Jeelaga & Co. as Cost Auditors for 2026-27. The company also accepted the resignation of Mr. R Ramachandra as Chief Financial Officer, effective May 31, 2026.

Key Highlights

  • Board approved audited financial results for Q4 and year ended March 31, 2026.
  • Q4 FY26 Net Sales from Operations stood at ₹21.03 Cr; Profit from Operations at ₹2.01 Cr.
  • FY26 Net Sales from Operations reached ₹70.38 Cr; Profit from Operations at ₹4.92 Cr.
  • Internal and Cost Auditors re-appointed for the fiscal year 2026-27.
  • Mr. R Ramachandra resigned as Chief Financial Officer, effective May 31, 2026.